What's Happening?
Medical Component Specialists, a leading provider of precision medical components, has appointed Chris Hester as its new President and CEO, effective April 27, 2026. Hester's appointment is part of the company's strategic leadership expansion aimed at driving
international growth and capacity scaling. With over 30 years of experience in manufacturing and corporate leadership, Hester is expected to lead the company through a period of significant expansion, including the operational launch of a new state-of-the-art manufacturing facility in Costa Rica. This facility, located in a free trade zone, features a proprietary automated grinding process and is set to double its capacity within six months to meet global demand.
Why It's Important?
The appointment of Chris Hester as CEO is a strategic move by Medical Component Specialists to enhance its global footprint and innovation in the medical device industry. Hester's extensive experience in optimizing manufacturing processes and developing new markets is crucial for the company's aggressive scaling strategy. The new Costa Rican facility represents a significant investment in scalable innovation, which is expected to deliver immediate capacity and value benefits to manufacturers. This expansion positions the company to better serve its clients, including major medical device OEMs, and underscores its commitment to driving the future of medical device innovation.
What's Next?
Under Hester's leadership, Medical Component Specialists is poised to capitalize on its expanded global footprint. The company plans to double the capacity of its new Costa Rican facility within the next six months, which will support its aggressive growth strategy. As the company scales its operations, it is likely to explore new markets and partnerships to further enhance its position in the medical device industry. Stakeholders will be watching closely to see how Hester's strategic vision translates into tangible growth and innovation.
